NCT07124910View on ClinicalTrials.gov

Comparison of Epi-ON Corneal Collagen Crosslinking Performed Using an 18-Minute UVA Exposure vs. a 24-Minute UVA Exposure on Eyes With Ectatic Corneal Diseases

PHASE3Not yet recruitingINTERVENTIONAL
Enrollment

485

Participants

Timeline

Start Date

August 31, 2025

Primary Completion Date

December 31, 2025

Study Completion Date

February 28, 2026

Conditions
KeratoconusEctasia of CorneaPellucid Marginal Corneal DegenerationForme Fruste Keratoconus (FFK)
Interventions
COMBINATION_PRODUCT

Epi-ON corneal cross-linking

"Corneal cross-linking involves the following steps:~* applying riboflavin (Vitamin B2 eye drops) to the eye, then~* exposing the eye to ultraviolet (UV-A) light"

Sponsors
All Listed Sponsors
lead

Clinical Research Consultants, Inc.

INDUSTRY

NCT07124910 - Comparison of Epi-ON Corneal Collagen Crosslinking Performed Using an 18-Minute UVA Exposure vs. a 24-Minute UVA Exposure on Eyes With Ectatic Corneal Diseases | Biotech Hunter | Biotech Hunter